When the Body Cannot Defend Itself
The immune system works quietly. Most people never think about it. It fights off threats without announcement, protects the body without asking for anything, and keeps life moving without interruption.
For patients with immune deficiency disorders, that quiet protection does not exist. Their bodies cannot produce enough antibodies to reliably defend against infection. Every season brings new risk. Every crowded room is a calculation. Every recovery from one illness bleeds into the beginning of the next.
Immunodeficiency infusion therapy changes that reality. By delivering concentrated antibodies directly into the body on a regular schedule, it restores the protection the immune system cannot maintain independently. Infections become less frequent. Recoveries become shorter. The exhausting cycle of illness that defines untreated immune deficiency begins, at last, to slow.
KabaFusion delivers immunodeficiency infusion therapy at home. This is not a reduced version of clinical care. It is clinical care at its most complete — brought to the patient, rather than requiring the patient to come to it.
How Immunodeficiency Infusion Therapy Works
The immune system’s most important output is immunoglobulins — the antibody proteins that patrol the bloodstream, identify pathogens, and neutralise them before they cause harm. In a healthy immune system, immunoglobulin production runs continuously and automatically. Infections are recognised quickly. Responses are mounted efficiently. Threats are cleared before they become serious.
In immune deficiency patients, that production is inadequate. The specific failure varies by diagnosis — some patients produce too few immunoglobulins, others produce ones that function poorly, others produce almost none. But the consequence is consistent: a body that cannot mount the antibody response it needs, leaving it vulnerable to infections that should pose no serious threat.
Immunodeficiency infusion therapy addresses this at the source. Immunoglobulins derived from the pooled plasma of thousands of healthy, screened donors are concentrated and delivered directly into the patient’s body — providing the broad antibody protection the patient’s own immune system cannot sustain. Administered on a regular schedule, immunodeficiency infusion therapy maintains the antibody levels needed to keep infections from taking hold.
The clinical outcomes for patients who begin immunodeficiency infusion therapy are consistently meaningful. Fewer infections. Fewer hospital admissions. Faster recoveries. A life that begins to feel less defined by illness and more defined by everything else.
The Conditions KabaFusion Treats
KabaFusion’s immunodeficiency infusion therapy programme serves patients across every primary and secondary immune deficiency diagnosis — with every care plan built individually, in direct collaboration with the treating immunologist.
Primary Immunodeficiency
Primary immunodeficiency disorders are genetic. Present from birth and inherited through variations in immune system architecture, they encompass more than 450 distinct classified diseases. The most commonly treated conditions through KabaFusion’s programme include Common Variable Immunodeficiency, a widespread adult-onset primary immunodeficiency characterised by low levels of most immunoglobulin classes. X-Linked Agammaglobulinemia, a severe condition affecting males in which circulating antibodies are nearly absent from birth. Specific Antibody Deficiency, in which normal total immunoglobulin levels mask an inability to respond to specific pathogen categories. Hyper IgM Syndrome, defined by elevated IgM alongside critically deficient IgG and IgA. And Selective IgA Deficiency presenting with clinically significant recurrent infections.
Secondary Immunodeficiency
Secondary immunodeficiency develops over time as a consequence of another serious illness or its treatment. Chemotherapy, radiation, organ transplantation, hematologic malignancies, and long-term immunosuppressive therapy can all damage the immune system’s capacity to the point where immunodeficiency infusion therapy becomes necessary.
KabaFusion treats the full range of secondary immune deficiency presentations — including Good Syndrome, immunodeficiency associated with hematologic malignancies, and immune deficiency related to ongoing immunosuppressive treatment. Patients managing both the original illness and its immune consequences receive a care plan designed to support every dimension of their clinical situation.
IVIG Therapy — Four Decades of Evidence Behind Every Infusion
IVIG therapy is the most extensively studied intervention in immunodeficiency infusion therapy. Its evidence base spans more than forty years of clinical use. Its ability to reduce infection frequency, prevent organ damage from chronic infection, and restore meaningful quality of life is documented across thousands of studies in every major immune deficiency population.
Intravenous immunoglobulin is administered every three to four weeks. The dose is not standardised — it is individualised to each patient based on their IgG trough levels, clinical response, body weight, and the evolving guidance of their treating immunologist. KabaFusion’s clinical pharmacists manage this calibration as a living process — adjusting protocols as the patient’s needs change and maintaining the close communication with the prescribing physician that precise IVIG therapy management demands.
Every KabaFusion IVIG session follows a complete clinical process without exception. A thorough pre-infusion assessment before the infusion begins. Continuous vital sign monitoring throughout. A post-infusion observation period before the session is closed. Full documentation of every parameter and observation. And a detailed clinical report sent to the treating immunologist after every session — because the physician managing a patient’s immune deficiency needs accurate, current information about what is happening at home, not just what was planned in clinic.
SCIG Therapy — Treatment on the Patient’s Terms
For many immune deficiency patients, SCIG therapy is the option that changes not just their treatment but their relationship with it.
Subcutaneous immunoglobulin therapy delivers immunoglobulins beneath the skin in smaller, more frequent doses. The result is steadier immunoglobulin blood levels between sessions — a consistency that translates, for many patients, into more stable day-to-day wellbeing and fewer of the variability-driven symptoms that monthly IVIG cycles can produce.
The defining benefit of SCIG immunodeficiency infusion therapy is self-administration. Eligible patients learn to administer their own treatment at home, on a schedule they control, without the structural dependency on clinical appointments or nursing visit windows that IVIG requires. The treatment fits around work, family, and travel. It does not dictate them.
KabaFusion’s SCIG training programme is designed around one outcome: genuine, earned confidence. Training is structured and paced entirely to the individual patient. Each technique is practised until it is natural. No patient moves forward until they are ready. All supplies and equipment are delivered directly to the patient’s home. A dedicated pharmacist provides ongoing clinical oversight. And around-the-clock clinical support means that a patient managing their own immunodeficiency infusion therapy independently is never truly alone — at any hour, for any question, however small it seems.
What Specialisation Actually Means at KabaFusion
The word specialisation is used often in healthcare. At KabaFusion, it has a specific and verifiable meaning.
It means that every pharmacist and nurse working in the immunodeficiency infusion therapy programme has completed dedicated immunoglobulin therapy education before treating their first immune deficiency patient. That education covers the rate titration protocols specific to safe immunoglobulin infusion, the premedication strategies that reduce reaction risk, the adverse reaction recognition and management approaches unique to this patient population, and the documentation standards that support optimal clinical communication.
It means that KabaFusion maintains comprehensive longitudinal records for every immunodeficiency infusion therapy patient — tracking IgG trough levels, infusion history, infection frequency, and clinical response across every session and every month of treatment. These records build the clinical picture that allows treatment to be continuously refined rather than simply repeated.
It means that after every immunodeficiency infusion session, the treating immunologist receives a detailed clinical report — not because it is required, but because KabaFusion understands that the best outcomes in immune deficiency care are produced by the home infusion team and the prescribing physician working together, with continuous and information-rich communication flowing between them.
And it means that when a patient has a question at any hour, someone who knows their case is available to answer it.
Insurance and Financial Access
KabaFusion accepts Medicare, Medicaid, and most commercial insurance plans for immunodeficiency infusion therapy. A dedicated benefits team manages every aspect of the insurance process — prior authorisations, medical necessity documentation, coverage reviews, and payor challenges — on behalf of each patient.
The patient’s responsibility in the insurance process is to receive care. Everything else is KabaFusion’s.
When coverage is insufficient or unavailable, KabaFusion actively connects patients with manufacturer patient assistance programmes and additional financial support resources. The commitment is unconditional: financial circumstances should never prevent a patient from receiving the immunodeficiency infusion therapy they need.
How to Get Started
Immunologists and referring providers can begin immunodeficiency infusion therapy with KabaFusion through a fast, simple online referral. Most patients receive their first home infusion within days of referral completion.
KabaFusion serves patients across all 50 states — with the same clinical depth, the same specialised team, and the same 24-hour support availability wherever the patient lives.
Phone: 888.204.9304 Website: www.kabafusion.com Email: info@KabaFusion.com Referrals: kabafusion.com/easy-patient-referral-form
Care That Belongs to You
Immune deficiency asks patients to manage more than most people ever have to think about. It asks for vigilance, for planning, and for a relationship with medical care that is ongoing, complex, and deeply personal.
Immunodeficiency infusion therapy should meet that ask. It should provide reliable, expert, evidence-based protection — in the place where the patient is safest, most comfortable, and most able to live the life they want to live.
That is what KabaFusion delivers. And it is what every immune deficiency patient, in every part of this country, deserves to receive.
